Results 231 to 240 of about 356,920 (284)

Culturally Safe Assistive Technology Provision in Australia: Concept Mapping Perspectives From Aboriginal and Torres Strait Islander People

Australian Journal of Social Issues, EarlyView.
ABSTRACT Disparities in Assistive Technology (AT) access exist for Aboriginal and Torres Strait Islander peoples despite recent policy reforms. This paper brings together First Nations and Western academic ways of being, knowing and doing to deliver an AT practice analysis based upon primary data from two research reports into the cultural safety of AT
Shane Hearn, Vanessa Langenberg, Kristy Harper, Libby Callaway, Hilary O'Connell, Eleanor Kennett‐Smith, Natasha Layton   +6 more
wiley   +1 more source

Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real‐World Evidence

Annals of Neurology, EarlyView.
Objective The objective of this study was to compare the long‐term safety profiles of ocrelizumab and rituximab in persons with multiple sclerosis (MS). Methods Using retrospective data from the University of California (UC) Health System, we simulated a target clinical trial. The primary cohort from UC San Francisco (UCSF) and a validation cohort from
Gabriel Cerono, Bruce A.C. Cree, Stephen L. Hauser, Sergio E. Baranzini   +3 more
wiley   +1 more source

Gleaning the Rocky Shore? 2500 Years of Coastal Resource Use at Red Bluff 1, GunaiKurnai Country, SE Australia

Archaeology in Oceania, EarlyView.
ABSTRACT Shell middens in Gippsland along the eastern half of Victoria's coastline have usually been characterised as small, short‐duration camp sites with relatively low shell densities and low taxonomic diversity. Here we present new excavation results from a dense, high‐diversity site at Red Bluff near the eastern end of GunaiKurnai Country, a ...
Patrick Faulkner, Bruno David, David M. Kennedy, Fiona Petchey, Joanna Fresløv, Ashleigh J. Rogers, Jillian Garvey, Rachel Kirby, Runjie Yuan, Russell Mullett, John Stanisic, Kyne Krusic‐Golub, V. Ruth Pullin, Matthew C. McDowell, Robert J. Skelly, Anthony Romano, Vanessa N. L. Wong, GunaiKurnai Land and Waters Aboriginal Corporation   +17 more
wiley   +1 more source

[Social determination and determinants of malaria: a systematic review, 1980-2018Determinação social e determinantes sociais da malária: revisão sistemática, 1980-2018]. [PDF]

Rev Panam Salud Publica, 2019
Cardona-Arias JA, Salas-Zapata WA, Carmona-Fonseca J.   +2 more
europepmc   +1 more source

Impacto de los determinantes sociales en la tuberculosis

Tuberculosis disease poses a global threat to public health. Through the "End TB" strategy, the WHO aims to achieve a 95% reduction in tuberculosis deaths by 2035 compared to 2015, decrease the incidence rate by 90%, and ensure that no family affected by tuberculosis faces catastrophic costs due to the disease.
openaire   +1 more source

International Market Access and Poverty in Argentina [PDF]

Guido Porto
core  

Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient‐Reported Outcomes in a Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Withdrawal Trial

Arthritis &Rheumatology, EarlyView.
Objective Juvenile idiopathic arthritis (JIA) is associated with impaired overall health‐related quality of life (HRQoL). We evaluated the impact of tofacitinib on patient‐reported outcomes (PROs) in patients with JIA. Methods This was a post hoc analysis of a phase 3, randomized, double‐blind, placebo‐controlled withdrawal trial (NCT02592434) in ...
Hermine I. Brunner, Ekaterina Alexeeva, Marcia Bandeira, Ruy Carrasco, Jeffrey Chaitow, Peter Chiraseveenuprapund, Tracy V. Ting, Muferet Erguven, Beth Gottlieb, Sheila Knupp Oliveira, Pooja N. Patel, Seza Ozen, Claudia Saad Magalhaes, Inmaculada Calvo Penadés, David Gruben, Rebecca Germino, Holly B. Posner, Lori Stockert, Alberto Martini, Daniel J. Lovell, Nicolino Ruperto, for the Paediatric Rheumatology International Trials Organisation (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG)   +21 more
wiley   +1 more source

Performance of the Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Calculator in Rheumatoid Arthritis

Arthritis &Rheumatology, Accepted Article.
Objective Evaluate performance of the Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) calculator in rheumatoid arthritis (RA). Methods Patients with RA were matched up to 10 controls on age, sex, and enrollment year using national Veterans Health Administration (VHA), Medicare, and National Death Index data (2006‐2020).
Tate M. Johnson, Halie Frideres, Punyasha Roul, Joshua F. Baker, Brian C. Sauer, Grant W. Cannon, Isaac D. Smith, Gary A. Kunkel, Beth I. Wallace, Thomas R. Porter, Kaveh R. Bookani, Amarnath R. Annapureddy, Ted R. Mikuls, Bryant R. England   +13 more
wiley   +1 more source

[Addressing the digital determinants of health: Main advantages and challenges of digital health]. [PDF]

Aten Primaria
Alarcón Belmonte I, Jiménez Lozano AI, Sánchez Collado C, Forero Chaves V, Cabrera Majada A, García-Gutiérrez Gómez R.   +5 more
europepmc   +1 more source